All Stories

  1. The effect of intravenous isosorbide dinitrate in acute decompensated heart failure in hospital

    Article • International Journal of Clinical Pharmacy, April 2017, Springer Science + Business Media

    Dr Stéphane GIBAUD

  2. Spray-dried microparticles of glutathione and S-nitrosoglutathione based on Eudragit® FS 30D polymer

    Article • Annales Pharmaceutiques Françaises, March 2017, Elsevier

    Dr Stéphane GIBAUD

  3. Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines

    Article • Drug Delivery, December 2015, Taylor & Francis

    Dr Stéphane GIBAUD

  4. Phthalimido–ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity

    Article • International Journal of Pharmaceutics, August 2015, Elsevier

    Dr Stéphane GIBAUD

  5. Synthesis and characterization ofS-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor

    Article • Expert Opinion on Drug Delivery, March 2015, Informa Healthcare

    Dr Stéphane GIBAUD, Prof Catarina Pinto Reis

  6. Effect of intravenous hydration in patients receiving bisphosphonate therapy

    Article • International Journal of Clinical Pharmacy, September 2014, Springer Science + Business Media

    Dr Stéphane GIBAUD

  7. Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?

    Article • Annales Pharmaceutiques Françaises, May 2014, Elsevier

    Dr Stéphane GIBAUD

  8. The antitumor effects of an arsthinol–cyclodextrin complex in a heterotopic mouse model of glioma

    Article • European Journal of Pharmaceutics and Biopharmaceutics, November 2013, Elsevier

    Dr Stéphane GIBAUD

  9. Characterization of mitotane (o,p′-DDD) – cyclodextrin inclusion complexes: Phase-solubility method and NMR

    Article • Annales Pharmaceutiques Françaises, May 2013, Elsevier

    Dr Stéphane GIBAUD

  10. Microemulsions for oral administration and their therapeutic applications

    Article • Expert Opinion on Drug Delivery, June 2012, Informa Healthcare

    Dr Stéphane GIBAUD

  11. Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis

    Article • PLoS Neglected Tropical Diseases, September 2011, PLOS

    Dr Stéphane GIBAUD, Dr Christopher McCabe

  12. Place du mitotane dans la prise en charge du carcinome corticosurrénalien

    Article • Actualités Pharmaceutiques Hospitalières, February 2011, Elsevier

    Dr Stéphane GIBAUD

  13. Speciation of arsenic in urine following intravenous administration of arsthinol in mice

    Article • European Journal of Drug Metabolism and Pharmacokinetics, July 2010, Springer Science + Business Media

    Dr Stéphane GIBAUD

  14. Microemulsion of mitotane

    Article • Drug Development and Industrial Pharmacy, March 2010, Taylor & Francis

    Dr Stéphane GIBAUD

  15. Arsenic-Based Drugs: From Fowler’s Solution to Modern Anticancer Chemotherapy

    Article • January 2010, Springer Science + Business Media

    Dr Stéphane GIBAUD

  16. Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells

    Article • Journal of Pharmacy and Pharmacology, October 2009, Wiley

    Dr Stéphane GIBAUD

  17. Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells

    Article • Journal of Pharmacy and Pharmacology, October 2009, Wiley

    Dr Stéphane GIBAUD

  18. Development of microemulsion of mitotane for improvement of oral bioavailability

    Article • Drug Development and Industrial Pharmacy, September 2009, Taylor & Francis

    Dr Stéphane GIBAUD

  19. De l’érythropoïétine recombinante aux agents stimulant l’érythropoïèse

    Article • Actualités Pharmaceutiques Hospitalières, May 2009, Elsevier

    Dr Stéphane GIBAUD

  20. Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2008, Elsevier

    Dr Stéphane GIBAUD

  21. Organoarséniés dérivés du 2-phényl- [1,3,2]dithiarsolane-4-yl)-méthanol (AsIII) à propriétés antileucémiques : des trypanosomicides aux anticancéreux

    Article • Annales Pharmaceutiques Françaises, May 2007, Elsevier

    Dr Stéphane GIBAUD

  22. Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice

    Article • Journal of Organometallic Chemistry, February 2007, Elsevier

    Dr Stéphane GIBAUD

  23. (2-Phenyl-[1,3,2]dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity

    Article • Journal of Organometallic Chemistry, February 2006, Elsevier

    Dr Stéphane GIBAUD

  24. Cyclodextrin Inclusion Complexes of the Central Analgesic Drug Nefopam

    Article • Drug Development and Industrial Pharmacy, January 2006, Taylor & Francis

    Dr Stéphane GIBAUD

  25. Melarsoprol–cyclodextrins inclusion complexes

    Article • International Journal of Pharmaceutics, December 2005, Elsevier

    Dr Stéphane GIBAUD

  26. Poly(ε-caprolactone) and Eudragit® microparticles containing fludrocortisone acetate

    Article • International Journal of Pharmaceutics, January 2004, Elsevier

    Dr Stéphane GIBAUD, Professor of university Prof. Dr. Najim A. Jabir Al awwadi Jabir Al awwadi

  27. Slow-release melarsoprol microparticles

    Article • International Journal of Pharmaceutics, August 2002, Elsevier

    Dr Stéphane GIBAUD

  28. Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods

    Article • International Journal of Pharmaceutics, August 2002, Elsevier

    Dr Stéphane GIBAUD

  29. Polyisobutylcyanoacrylate nanoparticles as drug carriers: influence of sulfur dioxide on the physico-chemical characteristics of ciprofloxacin- and doxorubicin-loaded nanoparticles

    Article • International Journal of Pharmaceutics, May 1998, Elsevier

    Dr Stéphane GIBAUD

  30. Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF)

    Article • Journal of Controlled Release, March 1998, Elsevier

    Dr Stéphane GIBAUD

  31. Article • Pharmaceutical Research, January 1997, Springer Science + Business Media

    Dr Stéphane GIBAUD

  32. Cells Involved in the Capture of Nanoparticles in Hematopoietic Organs

    Article • Journal of Pharmaceutical Sciences, September 1996, Elsevier

    Dr Stéphane GIBAUD

  33. Increased bone marrow toxicity of doxorubicin bound to nanoparticles

    Article • European Journal of Cancer, January 1994, Elsevier

    Dr Stéphane GIBAUD

  34. Detection of bacterial adenosine triphosphate through bioluminescence, applied to a rapid sterility test of injectable preparations

    Article • Analytica Chimica Acta, December 1991, Elsevier

    Dr Stéphane GIBAUD